Skip to main content
. Author manuscript; available in PMC: 2019 Sep 1.
Published in final edited form as: Clin Rheumatol. 2018 May 4;37(9):2497–2504. doi: 10.1007/s10067-018-4121-3

Figure 2.

Figure 2

Flow diagram illustrating which of the 1,203 participants (contributing 1808 knees) from figure 2 were assessed for the outcomes of interest including KL worsening, medial JSN worsening, new knee pain, and less knee pain.